Correlation Between Clinuvel Pharmaceuticals and Inolife Technologies

Can any of the company-specific risk be diversified away by investing in both Clinuvel Pharmaceuticals and Inolife Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Clinuvel Pharmaceuticals and Inolife Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Clinuvel Pharmaceuticals and Inolife Technologies, you can compare the effects of market volatilities on Clinuvel Pharmaceuticals and Inolife Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Clinuvel Pharmaceuticals with a short position of Inolife Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Clinuvel Pharmaceuticals and Inolife Technologies.

Diversification Opportunities for Clinuvel Pharmaceuticals and Inolife Technologies

0.39

Correlation Coefficient

Clinuvel Pharmaceuticals  Inolife Technologies

Weak diversification

The 3 months correlation between Clinuvel and Inolife is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Clinuvel Pharmaceuticals and Inolife Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inolife Technologies and Clinuvel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Clinuvel Pharmaceuticals are associated (or correlated) with Inolife Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inolife Technologies has no effect on the direction of Clinuvel Pharmaceuticals i.e., Clinuvel Pharmaceuticals and Inolife Technologies go up and down completely randomly.

Pair Corralation between Clinuvel Pharmaceuticals and Inolife Technologies

Assuming the 90 days horizon Clinuvel Pharmaceuticals is expected to generate 10.9 times less return on investment than Inolife Technologies. But when comparing it to its historical volatility, Clinuvel Pharmaceuticals is 3.68 times less risky than Inolife Technologies. It trades about 0.01 of its potential returns per unit of risk. Inolife Technologies is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  0.13  in Inolife Technologies on February 23, 2024 and sell it today you would lose (0.10) from holding Inolife Technologies or give up 76.92% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	91.33%
Values	Daily Returns

Clinuvel Pharmaceuticals  vs.  Inolife Technologies

Clinuvel Pharmaceuticals

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Clinuvel Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable essential indicators, Clinuvel Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders.

Inolife Technologies

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Inolife Technologies are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady technical and fundamental indicators, Inolife Technologies displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Clinuvel Pharmaceuticals and Inolife Technologies

The main advantage of trading using opposite Clinuvel Pharmaceuticals and Inolife Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Clinuvel Pharmaceuticals position performs unexpectedly, Inolife Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inolife Technologies will offset losses from the drop in Inolife Technologies' long position.

The idea behind Clinuvel Pharmaceuticals and Inolife Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..